Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.

Am J Respir Crit Care Med · 2026 · PMC13424836 · PMID 42104009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Of the 57 consistently changing proteins, 12 showed mild but nominally significant correlations with cardiopulmonary hemodynamic changes at week 24 in a direction of improvement.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.